DK1853158T3 - Afbalanceret fysiologisk overvågnings- og behandlingsanlæg - Google Patents

Afbalanceret fysiologisk overvågnings- og behandlingsanlæg Download PDF

Info

Publication number
DK1853158T3
DK1853158T3 DK06735761.6T DK06735761T DK1853158T3 DK 1853158 T3 DK1853158 T3 DK 1853158T3 DK 06735761 T DK06735761 T DK 06735761T DK 1853158 T3 DK1853158 T3 DK 1853158T3
Authority
DK
Denmark
Prior art keywords
patient
glucose
blood
monitoring
physiological
Prior art date
Application number
DK06735761.6T
Other languages
English (en)
Inventor
Timothy Valk
Jeffrey Valk
Original Assignee
Admetsys Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Admetsys Corp filed Critical Admetsys Corp
Application granted granted Critical
Publication of DK1853158T3 publication Critical patent/DK1853158T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/1407—Infusion of two or more substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16804—Flow controllers
    • A61M5/16827—Flow controllers controlling delivery of multiple fluids, e.g. sequencing, mixing or via separate flow-paths

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Business, Economics & Management (AREA)
  • Vascular Medicine (AREA)
  • General Business, Economics & Management (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Claims (2)

1. Aniæg (10) ti! overvågning og styring af biodglukoseniveauer i en patient, hvilket anlæg omfatter: en glukoseovervågningsenhed (80) til måling af biodglukoseniveauer på patienten; en styreindretning (30), som er operativt forbundet med glukoseovervågningsenheden (80); og en udleveringsmekanisme (40) med mange kanaler, og som er operativt forbundet med styreindretningen (30), kendetegnet ved, at styreindretningen (30) har en styrelogik, som er indrettet til at kunne overvåge, modtage og oplagre blodglukoseniveau-data fra glukoseovervågningsenheden (80) med henblik på at observere og klassificere mønstre i den fysiologiske opførsel og omsætte biodglukosedata-niveauet til et udgangsstyresignal indeholdende information vedrørende administration af mindst to lægemidler, hvilken udleveringsmekanisme er indrettet til at kunne modtage det nævnte udgangsstyresignal fra nævnte styreindretning (30), og hvor udleveringsmekanismen (40) ved infusion kan tilføre mindst to lægemidler til patienten på grundlag af nævnte information, som er indeholdt i nævnte udgangsstyresignal til styring af patientens biodglukoseniveauer; og hvor de mindst to lægemidler er insulin og glukose.
2, Anlæg ifølge krav 1, øg søm kan overvåge og styre mere end en i forvejen bestemt fysiologisk parameter.
DK06735761.6T 2005-02-22 2006-02-22 Afbalanceret fysiologisk overvågnings- og behandlingsanlæg DK1853158T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85657505P 2005-02-22 2005-02-22
PCT/US2006/006229 WO2006091650A2 (en) 2005-02-22 2006-02-22 Balanced physiological monitoring and treatment system

Publications (1)

Publication Number Publication Date
DK1853158T3 true DK1853158T3 (da) 2015-07-13

Family

ID=36927980

Family Applications (2)

Application Number Title Priority Date Filing Date
DK13159283.4T DK2609855T3 (da) 2005-02-22 2006-02-22 Balanceret fysiologisk overvågnings- og behandlingssystem
DK06735761.6T DK1853158T3 (da) 2005-02-22 2006-02-22 Afbalanceret fysiologisk overvågnings- og behandlingsanlæg

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK13159283.4T DK2609855T3 (da) 2005-02-22 2006-02-22 Balanceret fysiologisk overvågnings- og behandlingssystem

Country Status (5)

Country Link
EP (2) EP2609855B1 (da)
DK (2) DK2609855T3 (da)
ES (1) ES2535135T3 (da)
PL (1) PL1853158T3 (da)
WO (1) WO2006091650A2 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8956291B2 (en) 2005-02-22 2015-02-17 Admetsys Corporation Balanced physiological monitoring and treatment system
NZ548290A (en) * 2006-12-30 2009-09-25 Safer Sleep Ltd Notification system
US9220837B2 (en) 2007-03-19 2015-12-29 Insuline Medical Ltd. Method and device for drug delivery
WO2008114223A1 (en) 2007-03-19 2008-09-25 Insuline Medical Ltd. Drug delivery device
US8622991B2 (en) 2007-03-19 2014-01-07 Insuline Medical Ltd. Method and device for drug delivery
US7679504B2 (en) * 2007-05-16 2010-03-16 General Electric Company System and method of discovering, detecting and classifying alarm patterns for electrophysiological monitoring systems
EP2231229A1 (en) 2007-12-18 2010-09-29 Insuline Medical Ltd. Drug delivery device with sensor for closed-loop operation
WO2010011805A1 (en) * 2008-07-24 2010-01-28 Admetsys Corporation Device and method for automatically sampling and measuring blood analytes
WO2010014963A2 (en) * 2008-07-31 2010-02-04 Government Of The United States As Represented By The Secretary Of The Army Universal models for predicting glucose concentration in humans
CA2743027C (en) 2008-11-07 2016-04-12 Insuline Medical Ltd. Device and method for drug delivery
US8448499B2 (en) 2008-12-23 2013-05-28 C A Casyso Ag Cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, a corresponding measuring system, and a corresponding method
DE102009045589A1 (de) * 2009-10-12 2011-04-14 Universitätsklinikum Freiburg Vorrichtung zur Behandlung eines Individuums mit Herzminderleistung, Herzstillstand oder Schlaganfall
EP2371284A1 (en) * 2010-03-24 2011-10-05 C A Casyso AG Method and apparatus for determining at least one evaluation parameter of a blood sample
WO2012036636A1 (en) * 2010-09-15 2012-03-22 Singapore Health Services Pte. Ltd. Drug infusion system and method for controlling blood pressure
AU2015258349B2 (en) * 2010-09-15 2017-12-21 Singapore Health Services Pte Ltd. Drug infusion system and method for controlling blood pressure
US10777313B2 (en) 2013-06-13 2020-09-15 Carefusion 303, Inc. Analytics regarding ventilated patients
US11183287B2 (en) * 2013-06-13 2021-11-23 Carefusion 303, Inc. Analytics regarding patient care
US10288630B2 (en) 2014-09-29 2019-05-14 C A Casyso Gmbh Blood testing system and method
US10175225B2 (en) 2014-09-29 2019-01-08 C A Casyso Ag Blood testing system and method
US10539579B2 (en) 2014-09-29 2020-01-21 C A Casyso Gmbh Blood testing system and method
US9897618B2 (en) 2014-09-29 2018-02-20 C A Casyso Gmbh Blood testing system
US10816559B2 (en) 2014-09-29 2020-10-27 Ca Casyso Ag Blood testing system and method
US10295554B2 (en) 2015-06-29 2019-05-21 C A Casyso Gmbh Blood testing system and method
CN105433909B (zh) * 2015-12-29 2018-06-12 中国人民解放军空军总医院 前庭平衡功能检查、习服、矫治设备
US10473674B2 (en) 2016-08-31 2019-11-12 C A Casyso Gmbh Controlled blood delivery to mixing chamber of a blood testing cartridge
US10843185B2 (en) 2017-07-12 2020-11-24 Ca Casyso Gmbh Autoplatelet cartridge device

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4538616A (en) * 1983-07-25 1985-09-03 Robert Rogoff Blood sugar level sensing and monitoring transducer
FR2634382B1 (fr) * 1988-07-21 1990-10-26 Applic Techn Photoniques Pancreas artificiel
AU4967596A (en) * 1995-02-07 1996-09-04 Gensia, Inc. Feedback controlled drug delivery system
US5860957A (en) 1997-02-07 1999-01-19 Sarcos, Inc. Multipathway electronically-controlled drug delivery system
US20010044584A1 (en) * 1997-08-28 2001-11-22 Kensey Kenneth R. In vivo delivery methods and compositions
US7483743B2 (en) 2000-01-11 2009-01-27 Cedars-Sinai Medical Center System for detecting, diagnosing, and treating cardiovascular disease
US6980958B1 (en) * 2000-01-11 2005-12-27 Zycare, Inc. Apparatus and methods for monitoring and modifying anticoagulation therapy of remotely located patients
US7204823B2 (en) * 2001-12-19 2007-04-17 Medtronic Minimed, Inc. Medication delivery system and monitor
CA2522755A1 (en) * 2003-04-16 2004-11-04 Drexel University Acoustic blood analyzer for assessing blood properties
US8998808B2 (en) * 2003-06-19 2015-04-07 Wayne State University System for identifying patient response to anesthesia infusion
DE10352456A1 (de) * 2003-11-07 2005-07-28 Basibüyük, Halil Verfahren und Vorrichtung zur Verabreichung von flüssigen Medikamenten an einem Patienten

Also Published As

Publication number Publication date
EP1853158A4 (en) 2009-09-09
ES2535135T3 (es) 2015-05-05
EP1853158B8 (en) 2015-06-17
EP1853158A2 (en) 2007-11-14
PL1853158T3 (pl) 2016-01-29
EP2609855A1 (en) 2013-07-03
DK2609855T3 (da) 2024-02-12
EP2609855B1 (en) 2023-11-15
WO2006091650A3 (en) 2006-12-07
WO2006091650A2 (en) 2006-08-31
EP1853158B1 (en) 2015-04-08

Similar Documents

Publication Publication Date Title
DK1853158T3 (da) Afbalanceret fysiologisk overvågnings- og behandlingsanlæg
US9421332B2 (en) Balanced physiological monitoring and treatment system
US20230087860A1 (en) Insulin Management
JP4495962B2 (ja) ドラッグデリバリを滴定する装置および方法
Weintrob et al. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion
JP5661651B2 (ja) 低血糖のリスク査定およびなだらかなインスリン放出の減少による、ｃｇｍに基づいた低血糖の予防
JP5604112B2 (ja) 少なくとも１つの薬剤の注入のための装置
US20080306353A1 (en) Calculation device for metabolic control of critically ill and/or diabetic patients
Abraham et al. Effectiveness of a predictive algorithm in the prevention of exercise-induced hypoglycemia in type 1 diabetes
JP2017506757A (ja) インスリン管理
JP2022523973A (ja) 栄養を支援する栄養供給の効率
AU2002322761A1 (en) Apparatuses and methods for titrating drug delivery
JP2003079723A (ja) 糖尿病管理装置
JP2017526426A (ja) 被験者の心臓血管状態を監視および制御するためのシステムおよび方法
Michard et al. The future of intraoperative blood pressure management
US11197956B2 (en) Portal system-based bionic pancreas
JP2014500100A (ja) 人間又は動物の対象におけるボレミック状態の観察
US20150286797A1 (en) System and method for administering medication
Wolpert A Clinician's Perspective on Some of the Challenges in" Closing the Loop"
Gore et al. Except for alanine, muscle protein catabolism is not influenced by alterations in glucose metabolism during sepsis
Packer Patient care using closed-loop computer control
Zuhri et al. Management of Diabetic Ketoacidosis Concomitant With Acute Myocardial Infarction With Acute Heart Failure: A Case Report
Wilson Impact of real-time continuous glucose monitoring on children and their families
Keeling-Johnson et al. Immediate Postoperative Management of Cardiac Surgery Patients
US20060085136A1 (en) Method and system for determining an optimal amount of a pharmaceutical to be administered to a patient during surgery